Evaluation of the Effectiveness of a Digital Device for Remote Monitoring of Adapted Physical Activity in Patients with Chronic Diseases FReSH-59394-en test SGsix Evaluation of the Effectiveness of a Digital Device for Remote Monitoring of Adapted Physical Activity in Patients with Chronic Diseases TELE-APA FReSH-59394-en Walma Gharbi ASSOCIATION DES UTILISATEURS DE DOSSIERS INFORMATISES EN PEDIATRIE, OBSTETRIQUE ET GYNECOLOGIE (AUDIPOG) AEPEI (ASSOCIATION POUR L&#039;ETUDE ET LA PREVENTION DES L&#039;ENDOCARDITE INFECTIEUSE) France Recherche en Santé Humaine (FReSH) AGENCE DE L ENVIRONNEMENT ET DE LA MAITRISE DE L ENERGIE (ADEME) ASS RECHERCHE EPIDEMIOLOGIQUE REGISTRES (ARER68) null Jérôme;PALAZZOLO Walma;Gharbi ANSM CESREES digital health remote monitoring apa chronic diseases Addiction medicine Chronic Environmental determinants Behavioral determinants null This study evaluates the use of a digital platform that enables patients with chronic conditions to receive remote support for adapted physical activity. The platform allows users to schedule sessions, track physical activity, communicate with healthcare professionals, and enter data related to their health status. The study aims to measure the impact of this system on participants’ physical activity levels, program adherence, and quality of life. France Auvergne Rhône-Alpes Bourgogne Franche-Comté Individus General population Female Male Other Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Patients aged 18 or older; with a chronic condition compatible with participating in adapted physical activity; who have a prescription or recommendation for adapted physical activity when required; who have access to equipment that allows them to use the digital platform; and who have given their consent to participate in the study. Medical contraindications to participating in adapted physical activity; inability to use the digital device; inability to follow the study procedures; refusal or withdrawal of consent; simultaneous participation in another study that could interfere with the results. Clinical data Paraclinical data (non-biological) The Scientific and Steering Committee is responsible for overseeing the study, validating scientific and methodological approaches, and monitoring data quality and utilization. It brings together representatives from research teams, healthcare professionals, and experts in digital health. To evaluate the feasibility and acceptability of using a digital platform for remote monitoring of adapted physical activity in patients with chronic diseases, particularly with regard to platform usage, program adherence, and the completeness of the data collected. To assess changes in participants&#039; physical activity levels over the follow-up period. To assess changes in participants&#039; self-reported quality of life. Assess participation in adapted physical activity sessions. Assess the frequency and duration of use of the digital platform. Identify the challenges faced by participants and professionals when using the system. Assess participant and professional satisfaction with the digital platform. Data were collected at enrollment and then daily via the medication-tracking app. Questionnaires were completed at enrollment, at the midpoint, and at the end of the study. Complete enumeration (including consecutive recruitment) Probability Administrative database (employees pupils students etc.) < 500 individuals Measurements and tests Observation (clinical or behavioural) Other A mobile app used by participants to report when they take their medication, receive reminders, and provide information on their adherence and satisfaction. Data are collected automatically or entered directly by participants throughout the study. SRC-COMPLIANCE-MOBILE-001 Data enrichment through cross-referencing Clinical source Clinical record Interventional Study Interventional Study Monitoring by contact with the participant (mail, e-mail, telephone etc.) 180 Ongoing study The data is hosted on a secure infrastructure located in France or in the European Union, in accordance with applicable data protection and security requirements. Open access Data files are regularly checked for completeness. Missing data are identified and documented. The key variables used to monitor adherence are checked before each analysis. https://data.example.org/observance-mobile/data-access-plan A confidentiality agreement may be required before any access to individual data or data that poses a risk of re-identification. Authorized users agree to comply with the applicable confidentiality and security rules. https://data.example.org/observance-mobile/access-request Individual identifying data are not publicly accessible. Any Reuse Sophie;MARTIN Any publication or communication that uses the data must cite the OBSERVANCE-MOBILE study and the dataset in accordance with the citation guidelines established by the study principal investigator. Any scientific works, publications, or presentations resulting from the use of the data must be submitted to the principal investigator prior to their dissemination, in accordance with the defined access conditions. Access to the data is restricted to authorized individuals working on scientific or research projects consistent with the study’s objectives. All requests for access are subject to approval by the study’s principal investigator. Terms and Conditions for the Provision of Aggregated Data